PepsiCo Rebounds but Options Turn Cautious After Q3

PEP gained 3.3% over the past week, broadly in line with beverage peers but doing so while options positioning shifted more defensive than at any point in months.

Among its closest comparables, TAP led the group with a 4.3% weekly gain, while KO actually fell 1.3% over the same period. PEP's 3.3% recovery put it near the middle of the pack, though the 2.2% pullback on Friday to $135.77 suggests the post-earnings relief trade is already fading. The stock is up roughly 3.5% over the past month, but that headline number covers a choppier ride: shares were changing hands near $125 when director Robert Pohlad made his move on October 14, the same day Q3 results were published.

The options market is the most charged signal this week. Put demand has jumped well above recent norms: the put/call ratio closed at 0.66 on Thursday, more than two standard deviations above its 20-day average of 0.58. That is not panic territory, the 52-week high is 0.92, but it is the highest defensive tilt seen in several months and a meaningful shift from the 0.52 range that prevailed through mid-October. The contrast with the lending market is sharp. Borrow availability is essentially unconstrained, and cost to borrow has fallen to around 0.23%, roughly half its level a month ago. Short interest is only 1.7% of the free float, up about 11% from a month ago in share terms, but still firmly in the low-conviction range. Bears are not pressing hard in the stock loan market; whatever caution exists is being expressed through puts.

The analyst picture has settled into a cautious consensus since the Q3 print. In the days surrounding the October 9 results, targets came down across the board. Barclays trimmed to $126, Citi to $135, JP Morgan to $137, and Piper Sandler made the sharpest cut, to $140 from $176. The consensus mean now sits at roughly $141, only about 4% above the current price. Most ratings held at neutral or equivalent, with only a handful of houses maintaining outperform stances. The bear case is well documented: PBNA is losing share in soft drinks by management's own admission, North American snack volumes are under pressure, and commodity hedges rolling off into 2027 point to margin headwinds. The bull case rests on international momentum, where organic growth ran at 8% in Q3, and on a multi-year path to 2-3% organic sales growth. The earnings yield ranks in the 60th percentile of the universe, and EV/EBITDA has expanded slightly over the past month, now near 12x, reflecting the modest price recovery without a matching earnings upgrade.

The insider activity that preceded the Q3 print is the most concrete vote of confidence in the data. Director Pohlad spent roughly $17.9m buying shares on October 14 at $128.28, across several disclosed transactions, none of which was under a pre-arranged 10b5-1 plan. That is an open-market, discretionary purchase at the post-selloff lows, the clearest insider signal in recent months. The same week, Chairman and CEO Ramon Laguarta sold 30,000 shares at $135.13 on October 21, a $4.1m transaction also outside a 10b5-1 plan. The two moves point in opposite directions, a director buying the dip while the CEO trims into strength, leaving the net 90-day insider position mildly positive in share terms but without a single clear read.

Separately, alt data from SEC EDGAR XBRL flagged that Q2 buyback spend of $297m was the smallest second quarter for repurchases in two years, a data point worth monitoring as the company manages capital allocation alongside its margin recovery plan.

The next earnings event is scheduled for January 11, 2027, with 79 days to go. Between now and then, the level to watch is whether the put/call ratio sustains above two standard deviations from its mean, and whether the gap between the consensus price target and the current share price narrows through estimate revisions or price action.